Hormones and hair growth;Hormone und Haarwachstum

Hautarzt

Volumn 61, Issue 6, 2010, Pages 487-496

  Trueb R M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Alopecia; Hair aging; Hair growth; Hormones; Hypertrichosis

Indexed keywords

AROMATASE INHIBITOR; CORTISONE; ESTROGEN; GROWTH HORMONE; MELATONIN; PROLACTIN; THYROID HORMONE; AROMATASE; CHOLESTENONE 5ALPHA REDUCTASE; HORMONE;

ACROMEGALY; AGING; ANDROGEN METABOLISM; HAIR GROWTH; HAIR LOSS; HIRSUTISM; HUMAN; HYPERPROLACTINEMIA; HYPERTRICHOSIS; MALE TYPE ALOPECIA; REVIEW; THIRD TRIMESTER PREGNANCY; THYROID DISEASE; ADOLESCENT; ADULT; AGE; AGED; ALOPECIA; FEMALE; GROWTH, DEVELOPMENT AND AGING; HAIR; HYPERTHYROIDISM; HYPOGONADISM; HYPOTHYROIDISM; LARON SYNDROME; MALE; MENOPAUSE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; SEX DIFFERENCE; YOUNG ADULT;

ACROMEGALY; ADOLESCENT; ADULT; AGE FACTORS; AGED; ALOPECIA; AROMATASE; CHOLESTENONE 5 ALPHA-REDUCTASE; FEMALE; HAIR; HIRSUTISM; HORMONES; HUMANS; HYPERTHYROIDISM; HYPOGONADISM; HYPOTHYROIDISM; LARON SYNDROME; MALE; MENOPAUSE; MIDDLE AGED; PREGNANCY; SEX FACTORS; YOUNG ADULT;

EID: 77954427125     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-009-1890-2     Document Type: Review

References (30)

1. Bahta AW, Farjo N, Farjo B, Philpott MP (2008) Premature senescence of balding dermal papilla cells in vitro is associated with p16(INK4a) expression. J Invest Dermatol 128:1088-1094
2. Bangha E, Elsner P, Kistler GS (1997) Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). Influence of the application time point. Dermatology 195:248-252
3. Billoni N, Buan B, Gautier B et al (2000) Thyroid hormone receptor ß1 is expressed in human hair follicle. Br J Dermatol 142:645-652
4. Blume-Peytavi U, Kunte C, Krisp A et al (2007) Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women. J Dtsch Dermatol Ges 5:391-395
5. Bodo E, Kromminga A, Biro T et al (2009) Human female hair follicles are a direct, nonclassical target for thyroid-stimulating hormone. J Invest Dermatol 129:1126-1139
6. Conrad F, Paus R (2004) Östrogene und der Haarfollikel. J Dtsch Dermatol Ges 2:412-423
7. Fischer TW, Burmeister G, Schmidt HW, Elsner P (2004) Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial. Br J Dermatol 150:341-345
8. Guy WB, Edmundson WF (1960) Diffuse cyclic hair loss in women. Arch Dermatol 81:205-227
9. Hamilton JB (1942) Male hormone stimulation is prerequisite and an incitement in common baldness. Am J Anat 71:451
10. Hoffman R (2004) Androgenetische Alopezie. Hautarzt 55:89-111
11. Imperato-McGinnley J, Guerrero L, Gautier T et al (1974) Steroid 5a-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 1213-1215
12. Itami S, Inui S (2005) Role of androgen in mesen-chymal epithelial interactions in human hair follicle. J Invest Dermatol Symp Proc 10:209-211
13. Li JJ, Mitchell LH, Dow RL (2010) Thyroid receptor agonists for the treatment of androgenetic alopecia. Bioorg Med Chem Lett 20:306-308
14. Lurie R, Ben-Amitai D, Laron Z (2004) Laron syndrome (primary growth hormone insensitivity): a unique model to explore the effect of insulin-like growth factor 1 deficiency on human hair. Dermatology 208:314-318
15. Mirmirani P, Karnik P (2010) Comparative gene expression profiling of senescent and androgenetic alopecia using microarray analysis. In: Trüeb RM, Tobin DJ (Hrsg) Aging hair. Springer, Berlin Heidelberg New York Tokyo (im Druck)
16. Moltz L (1988) Hormonale Diagnostik der sog. an-drogenetischen Alopezie der Frau. Geburtsh Frauenheil 48:203-214
17. OrfanosCE, Hertel H (1988) Haarwachstumsstörungen bei Hyperprolaktinämie. Z Hautkr 63:23-26
18. Orme S, Cullen DR, Messenger AG (1999) Diffuse female hair loss: are androgens necessary? Br J Dermatol 141:521-523
19. Paus R (1996) Control of the hair cycle and hair diseases as cycling disorders. Curr Opin Dermatol 3:248-258
20. Paus R, Müller-Röver S, Botchkarev VA (1999) Chro-nobiology of the hair follicle: hunting the .,hair cycle clock". Investig Dermatol Symp Proc 4:338-345 (Pubitemid 30085832)
21. Price VH, Roberts JL, Hordinsky M et al (2000) Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol 43:768-776
22. Rushton DH, Ramsay ID, James KC et al (1990) Biochemical and trichological characterization of diffuse alopecia in women. Br J Dermatol 123:187197
23. Sawaya ME, Price VH (1997) Different levels of 5al-pha-reductase type I and II, aromatase and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 109:296-300
24. Schell H, Kiesewetter F, Seitdel C, Hintenstern J von (1991) Cell cycle kinetics of human anagen hair bulbs in thyroid disorders determined by DNA flow cytometry. Dermatologica 182:23-26
25. Schmidt JB (1994) Hormonal basis of male and female androgenic alopecia: clinical relevance. Skin Pharmacol 7:61-66
26. Slominski A, Wortsman J, Tobin DJ (2005) The cutaneous serotoninergic/melatoninergic system: securing a place under the sun. FASEB J 19:176-194
27. Stenn KS, Paus R, Dutton T, Sarba B (1993) Gluco-corticoid effect on hair growth initiation: a reconsideration. Skin Pharmacol 6:125-134
28. Utiger RD (2001) Estrogen, thyroxine binding in serum and thyroxine therapy. N Engl J Med 344:1784-1785
29. Vexiau P, Chaspoux C, Boudou P et al (2002) Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial. Br J Dermatol 146:992999
30. Wolff H, Kunte C (1998) Die Behandlung der an-drogenetischen Alopezie des Mannes mittels systemischer 5a-Reduktase-Hemmung. Hautarzt 49:813-817